McMinn Rachel
SEC CIK 1606302 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NGNE | Neurogene Inc. | CEO, Dir | 1.34M | $969.0K | $74.0K | 4 | 2024-11-22 | 2026-03-26 |
Most active insiders at NGNE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cvijic Christine Mikail | Pres, CFO, Dir | — | $900.0K |
| 2 | Cobb Stuart | CSO | — | $141.4K |
| 3 | McMinn Rachel | CEO, Dir | — | $74.0K |
| 4 | Jordan Julie | Chief Medical Off | — | $18.1K |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-26 | NGNE | Neurogene Inc. | McMinn Rachel | CEO, Dir | S - Sale | $22.07 | -3,352 | 1.34M | -0.2% | -$74.0K | |
| D | 2026-02-24 | 2026-02-20 | NGNE | Neurogene Inc. | McMinn Rachel | CEO, Dir | A - Grant | $0.00 | +25.9K | 1.35M | +2% | $0 |
| D | 2025-03-28 | 2025-03-26 | NGNE | Neurogene Inc. | McMinn Rachel | CEO, Dir | A - Grant | $0.00 | +23.9K | 1.27M | +2% | $0 |
| 2024-11-25 | 2024-11-22 | NGNE | Neurogene Inc. | McMinn Rachel | CEO, Dir | P - Purchase | $20.40 | +47.5K | 1.30M | +4% | +$969.0K |
Purchase Sale Sale after option exercise All abbreviations